Rutin mitigates acetic acid-induced ulcerative colitis: novel coloprotective mechanism
Toxicology Research · 01.07.2024 · 13 (4)
DOI: 10.1093/toxres/tfae108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicology Research, online erschienen am 25.07.2024. Verfasst von Iman O Sherif und 2 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Hospital, Faculty of Medicine, Mansoura University, El Gomhoria Street, Mansoura 35516, Egypt. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Ulcerative colitis, an inflammatory bowel disease, is characterized by a status of oxidative stress and inflammation. Rutin is a natural flavonoid with many pharmacological activities and its role in acetic acid-induced ulcerative colitis through the high mobility group B1 (HMGB1)/ toll-like receptor-4 (TLR4)/ myeloid differentiation primary response protein 88 (MYD88)/ nuclear factor-kB (NF-kB) signaling pathway needs to be explored.
Methods
Four experimental groups were divided into control group, rutin group: treated with 100 mg/kg/day rutin orally for 10 days, acetic acid (AA) group: given intracolonic instillation of AA to induce ulcerative colitis, and acetic acid with rutin treatment (AA/Rutin) group.
Results
Acetic acid caused a marked increase in the colon weight/length ratio and induced colonic histopathological changes, leading to a marked rise in the colonic histopathological scores. Acetic acid exhibited a significant rise in LDH and CRP serum levels as well as TOS colonic levels, accompanied by a marked decline in TAS colonic contents compared to the control group. Moreover, AA-induced activation of the HMGB1/TLR4/MYD88/NF-kB signaling pathway. Rutin demonstrated a significant decrease in the colon weight/length ratio, ameliorated the colonic histopathological changes induced by AA, and exhibited a marked decline in the colonic histopathological scores. Rutin showed a significant decrease in serum LDH, and CRP levels as well as colonic TOS contents when compared with the AA group. Rutin suppressed the colonic activation of the HMGB1/TLR4/MYD88/NF-kB signaling pathway.
Conclusion
Rutin could be a promising coloprotective agent against AA-induced ulcerative colitis by targeting the HMGB1/TLR4/MYD88/NF-kB signaling pathway.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Emergency Hospital, Faculty of Medicine, Mansoura University, El Gomhoria Street, Mansoura 35516, Egypt.
- Chemistry Department, College of Science, Princess Nourah bint Abdulrahman University, Airport Road, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
- Pathology Department, Faculty of Veterinary Medicine, Mansoura University, El Gomhoria Street, Mansoura 35516, Egypt.
ORCID-Profile: Iman O Sherif, Nora H Al-Shaalan, Walaa F Awadin
Zitieren
APA
Sherif, I. O., Al-Shaalan, N. H., & Awadin, W. F. (2024). Rutin mitigates acetic acid-induced ulcerative colitis: novel coloprotective mechanism. Toxicology Research, 13(4). https://doi.org/10.1093/toxres/tfae108
Vancouver
Sherif IO, Al-Shaalan NH, Awadin WF. Rutin mitigates acetic acid-induced ulcerative colitis: novel coloprotective mechanism. Toxicology Research. 2024;13(4). doi:10.1093/toxres/tfae108
BibTeX
@article{Sherif2024,
author = {Sherif, Iman O and Al-Shaalan, Nora H and Awadin, Walaa F},
title = {Rutin mitigates acetic acid-induced ulcerative colitis: novel coloprotective mechanism},
journal = {Toxicology Research},
year = {2024},
volume = {13},
number = {4},
doi = {10.1093/toxres/tfae108}
}
EUVIMED